Advanced Medical Solutions Group (LON:AMS) Trading 14.4% Higher – What’s Next?

Shares of Advanced Medical Solutions Group plc (LON:AMS) rose 14.4% during mid-day trading on Tuesday . The company traded as high as GBX 218 ($2.67) and last traded at GBX 218 ($2.67). Approximately 1,169,792 shares were traded during trading, an increase of 142% from the average daily volume of 483,901 shares. The stock had previously closed at GBX 190.60 ($2.33).

Wall Street Analyst Weigh In

Separately, Berenberg Bank restated a “buy” rating and set a GBX 300 ($3.67) price target on shares of Advanced Medical Solutions Group in a report on Tuesday.

Advanced Medical Solutions Group Trading Up 14.4 %

The company has a debt-to-equity ratio of 37.01, a current ratio of 8.39 and a quick ratio of 4.58. The company’s 50 day moving average is GBX 204.23 and its two-hundred day moving average is GBX 220.08. The firm has a market cap of £467.72 million, a P/E ratio of 4,360.00, a PEG ratio of 5.00 and a beta of 0.74.

Insider Activity at Advanced Medical Solutions Group

In related news, insider Eddie Johnson sold 34,235 shares of the stock in a transaction dated Monday, November 11th. The shares were sold at an average price of GBX 218 ($2.67), for a total value of £74,632.30 ($91,326.85). 3.12% of the stock is owned by corporate insiders.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.